Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN

Pitofsky Jason sold 4,062 Regeneron Pharmaceuticals, Inc. shares (Form 4)

Traded Nov 4, 2026 · Filed Nov 6, 2026

On Nov 4, 2026, Pitofsky Jason (SVP Controller) sold 4,062 Regeneron Pharmaceuticals, Inc. shares at an average US$942.19 for US$3.83M, leaving 0 shares. Filed Nov 6, 2026 (Form 4).

Sold
4,062 shares
Price
US$942.19 average (US$939.57 to US$950.76)
Value
US$3.83M
Holding after
0 shares (held indirectly)
Trading plan
No
Role
SVP Controller

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 4, 2026Common StockOption exercise1,500US$726.535,772Direct
Nov 4, 2026Common StockOption exercise1,478US$644.547,250Direct
Nov 4, 2026Common StockOption exercise905US$492.008,155Direct
Nov 4, 2026Common StockSale439US$939.577,716Direct
Nov 4, 2026Common StockSale575US$940.467,141Direct
Nov 4, 2026Common StockSale982US$941.586,159Direct
Nov 4, 2026Common StockSale1,215US$942.314,944Direct
Nov 4, 2026Common StockSale529US$943.534,415Direct
Nov 4, 2026Common StockSale108US$944.224,307Direct
Nov 4, 2026Common StockSale35US$945.614,272Direct
Nov 4, 2026Common StockSale179US$950.760Indirect

Source

Download original · View original at SEC

Related